Bolt Biotherapeutics, Inc. (BOLT)
6.27
+2.08
(+49.64%)
USD |
NASDAQ |
Oct 23, 16:00
6.35
+0.08
(+1.28%)
After-Hours: 05:50
Bolt Biotherapeutics Net Income (Quarterly) : -7.72M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.72M |
| March 31, 2026 | -7.244M |
| December 31, 2025 | -6.631M |
| September 30, 2025 | -7.144M |
| June 30, 2025 | -8.561M |
| March 31, 2025 | -11.04M |
| December 31, 2024 | -15.94M |
| September 30, 2024 | -15.18M |
| June 30, 2024 | -21.20M |
| March 31, 2024 | -10.81M |
| December 31, 2023 | -17.90M |
| September 30, 2023 | -16.26M |
| June 30, 2023 | -18.06M |
| March 31, 2023 | -16.98M |
| Date | Value |
|---|---|
| December 31, 2022 | -20.00M |
| September 30, 2022 | -21.76M |
| June 30, 2022 | -22.66M |
| March 31, 2022 | -23.68M |
| December 31, 2021 | -27.16M |
| September 30, 2021 | -23.40M |
| June 30, 2021 | -23.58M |
| March 31, 2021 | -24.45M |
| December 31, 2020 | -31.04M |
| September 30, 2020 | -10.00M |
| June 30, 2020 | -11.06M |
| March 31, 2020 | -8.633M |
| December 31, 2019 | -9.362M |
| September 30, 2019 | -7.184M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | 7.725M |
| EPS Diluted (Quarterly) | -4.567 |
| Enterprise Value | 15.90M |
| Gross Profit Margin (Quarterly) | -3.32K% |
| Profit Margin (Quarterly) | -154.4K% |
| Earnings Yield | -262.2% |
| Normalized Earnings Yield | -247.27 |